Milestone Scientific Inc. (MLSS) stock
MLSSNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/309% below fair value
$0.31+0.02 (+5.86%)
Close on Nov 13, 2026Market cap $27.24MP/E –Yield –
Milestone Scientific r&d expenses
Research and development expenses are spending on new products and technology.
Milestone Scientific's R&D Expenses for the twelve months ending Dec 31, 2025 was $449.47K, down 47.7% year over year. For fiscal 2025 it was $449.47K, down 47.7% from the year before. Over ten years it grew 16.1% a year on average. The highest annual figure on record is $1.27M in fiscal 2016.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $449.47K | -47.7% |
| FY2024 | Dec 31, 2024 | $858.77K | +22.4% |
| FY2023 | Dec 31, 2023 | $701.38K | -39.0% |
| FY2022 | Dec 31, 2022 | $1.15M | +31.0% |
| FY2021 | Dec 31, 2021 | $878.21K | +185.3% |
| FY2020 | Dec 31, 2020 | $307.85K | +62.1% |
| FY2019 | Dec 31, 2019 | $189.92K | -22.7% |
| FY2018 | Dec 31, 2018 | $245.64K | -9.9% |
| FY2017 | Dec 31, 2017 | $272.75K | -78.5% |
| FY2016 | Dec 31, 2016 | $1.27M | +1159.7% |
| FY2015 | Dec 31, 2015 | $100.86K | +14.3% |
| FY2014 | Dec 31, 2014 | $88.24K | -53.9% |
| FY2013 | Dec 31, 2013 | $191.35K | +5.1% |
| FY2012 | Dec 31, 2012 | $181.98K | +29.9% |
| FY2011 | Dec 31, 2011 | $140.05K | -48.2% |
| FY2010 | Dec 31, 2010 | $270.49K | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $10.41K | -79.9% |
| Q2 FY2026 | Jun 30, 2026 | $6.61K | -98.2% |
| Q4 FY2025 | Dec 31, 2025 | $12.33K | -94.3% |
| Q3 FY2025 | Sep 30, 2025 | $16.23K | -93.0% |
| Q2 FY2025 | Jun 30, 2025 | $51.79K | -83.6% |
| Q1 FY2025 | Mar 31, 2025 | $369.12K | +291.8% |
| Q4 FY2024 | Dec 31, 2024 | $217.53K | +23.0% |
| Q3 FY2024 | Sep 30, 2024 | $232.06K | +36.1% |
| Q2 FY2024 | Jun 30, 2024 | $314.97K | +47.4% |
| Q1 FY2024 | Mar 31, 2024 | $94.21K | -32.9% |
| Q4 FY2023 | Dec 31, 2023 | $176.91K | -30.1% |
| Q3 FY2023 | Sep 30, 2023 | $170.48K | +2.6% |
| Q2 FY2023 | Jun 30, 2023 | $213.65K | -19.9% |
| Q1 FY2023 | Mar 31, 2023 | $140.35K | -69.8% |
| Q4 FY2022 | Dec 31, 2022 | $252.99K | -12.8% |
| Q3 FY2022 | Sep 30, 2022 | $166.19K | -53.3% |
| Q2 FY2022 | Jun 30, 2022 | $266.56K | +23.7% |
| Q1 FY2022 | Mar 31, 2022 | $464.47K | +2724.5% |
| Q4 FY2021 | Dec 31, 2021 | $290.17K | +310.1% |
| Q3 FY2021 | Sep 30, 2021 | $356.18K | +1561.4% |
| Q2 FY2021 | Jun 30, 2021 | $215.42K | +99.1% |
| Q1 FY2021 | Mar 31, 2021 | $16.44K | -84.7% |
| Q4 FY2020 | Dec 31, 2020 | $70.76K | -11.7% |
| Q3 FY2020 | Sep 30, 2020 | $21.44K | +170.0% |
| Q2 FY2020 | Jun 30, 2020 | $108.17K | +13.2% |
| Q1 FY2020 | Mar 31, 2020 | $107.48K | +1593.7% |
| Q4 FY2019 | Dec 31, 2019 | $80.11K | +167.2% |
| Q3 FY2019 | Sep 30, 2019 | $7.94K | +429.3% |
| Q2 FY2019 | Jun 30, 2019 | $95.53K | +877.3% |
| Q1 FY2019 | Mar 31, 2019 | $6.35K | -97.2% |
| Q4 FY2018 | Dec 31, 2018 | $29.98K | -2.6% |
| Q3 FY2018 | Sep 30, 2018 | $1.50K | -91.1% |
| Q2 FY2018 | Jun 30, 2018 | $9.78K | -91.9% |
| Q1 FY2018 | Mar 31, 2018 | $225.82K | +115.0% |
| Q4 FY2017 | Dec 31, 2017 | $30.78K | -94.0% |
| Q3 FY2017 | Sep 30, 2017 | $16.88K | – |
| Q2 FY2017 | Jun 30, 2017 | $120.07K | – |
| Q1 FY2017 | Mar 31, 2017 | $105.02K | – |
| Q4 FY2016 | Dec 31, 2016 | $514.43K | – |
See a number that looks wrong?